@rweichselbaum@SameerKeoleMD@ASTRO_org Research advocacy is certainly a critical need… not only in dollars but in seats at the table when trials and guidelines are cobbled together. Without the deep pockets of pharma patronage, radiation research funding is inevitablly more fragile.
Radiation oncology leadership need to simultaneously advocate for payment reform but emphasize that nothing else in the oncology world is as cost effective as radiation therapy.
Our economy spends more on a single drug—-pembrolizumab—-than all radiation treatments combined.
@wagcjner@michaelj0seph79@OleTimeHardball Clown take, bro.
Williams hit over .340 career versus Bob Feller, who had more heat than Mo could ever imagine.
Don’t assume players from the past weren’t highly skilled and don’t assume pitchers from the days before radar couldn’t bring it.
@jryckman3 My cheap solution has always been to put screenshots of critical isodose setups, sometimes DVH, and other treatment images or dose panel in my treatment summaries.
There’s a little bit of grunt work involved , but I am choosing / filtering what is communicated.
@coachprburkhead I’m at least 20 years older. ACL injuries have always been around but in the old days you got a big zipper scar and you just might be finished playing sports. The fact players can rehab and come back makes them seem more visible/common.